{"nct_id":"NCT00474786","title":"Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib","status":"COMPLETED","status_verified_date":"2013-10","start_date":"2007-09","start_date_type":null,"primary_completion_date":"2012-01","primary_completion_date_type":"ACTUAL","completion_date":"2013-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}